Close this search box.

Cannabis firm Kanabo appoints Tory MP Dr Daniel Poulter MP to the board

Major medical cannabis firm Kanabo Group has appointed Conservative MP, Dr Dan Poulter as a non-executive director.

The former Government health minister and chairperson of the All-Party Parliamentary Group (APPG) for Global Health, Dr Poulter has a detailed knowledge of the drugs and medicines regulatory framework in the UK. 

In an announcement on Tuesday 29 June, Kanabo said his experience in medical, governmental, and healthcare policy makes him ‘well positioned’ to support its mission to establish and lead a regulated medicinal cannabis market in the UK and Europe.

The company became only the second cannabis firm to list on the London Stock Exchange in February.

Its flagship product, the VapePod, is the first-ever medically certified vaporiser for cannabis oils.

Dr Dan Poulter MP
Dr Dan Poulter MP

Dr Poulter, a practicing NHS Psychiatrist has previously advocated for access to medical cannabis, believing that prescribed cannabis products could bring considerable health benefits to help people experiencing mental ill health and distress. 

He is vice-chair of the APPG on Medical Cannabis under Prescription and a member of the advisory council for the Conservative Drug Policy Reform Group.

Dr Poulter said: “As a doctor, I am increasingly aware of the potential of cannabis-based medicines. Cannabis products are fast becoming available that could deliver significant improvements to the lives of thousands of patients suffering from conditions ranging from chronic pain to post traumatic stress disorder.”

Avihu Tamir, CEO, Kanabo Group, said: “We are delighted to welcome Dr Dan Poulter, MP as a Non-Executive Director to our board. Dan brings a wealth of knowledge and insight into the business that strengthens our team as we build a medicinal cannabis market in the UK and Europe.” 

Kanabo is an established leader in medical cannabis research and innovation. As such, the company is creating a new standard in the industry by providing better and safer access to such cannabis medications. I am pleased to be able to lend my knowledge and experience to the company’s work in this crucially important endeavour.”

Chairman of the board, David Tsur, added: “We are delighted that Dr Dan Poulter has joined us and we’d like to warmly welcome him. He brings a wealth of experience and I’m sure will be a very valuable addition to the Board. It’s an exciting period for Kanabo to execute the company’s business plan and to expand its activity and strategic partnerships.”

[activecampaign form=31]




Related Posts

Related Posts


Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you


Browse by Tags




© 2023 Prohibition Holdings Ltd. All Rights Reserved.


Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?